|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.625 USD | +0.27% |
|
-10.67% | -17.38% |
| Mar. 13 | Stifel Adjusts Price Target on ClearPoint Neuro to $9 From $8, Maintains Buy Rating | MT |
| Mar. 12 | ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2000 Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| -17.38% | 152M | |
| +5.10% | 213B | |
| +3.60% | 177B | |
| +11.86% | 134B | |
| +16.66% | 99.13B | |
| +0.57% | 63.47B | |
| +16.98% | 53.69B | |
| -4.51% | 46.36B | |
| +0.86% | 41.09B | |
| +11.39% | 39.3B |
CLEARPOINT NEURO, INC. 
